MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 1401-69-0
Formula C46H77NO17MW 916.1Research-use catalog entryCOA/SDS by request

Tylosin

CAS Number: 1401-69-0

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
100 g
Purity
CAS号1401-69-0, 是Anti-infection类化合物, 分子量为916.1, 分子式C46H77NO17, 标准纯度Tylosin A ≥ 80%, Tylosin A+B+C+D ≥ 95%, active unit ≥
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
25 g
Purity
CAS号1401-69-0, 是Anti-infection类化合物, 分子量为916.1, 分子式C46H77NO17, 标准纯度Tylosin A ≥ 80%, Tylosin A+B+C+D ≥ 95%, active unit ≥
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 g
Purity
CAS号1401-69-0, 是Anti-infection类化合物, 分子量为916.1, 分子式C46H77NO17, 标准纯度Tylosin A ≥ 80%, Tylosin A+B+C+D ≥ 95%, active unit ≥
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
500 g
Purity
CAS号1401-69-0, 是Anti-infection类化合物, 分子量为916.1, 分子式C46H77NO17, 标准纯度Tylosin A ≥ 80%, Tylosin A+B+C+D ≥ 95%, active unit ≥
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: WBPYTXDJUQJLPQ-VMXQISHHSA-NC46H77NO17 | MW 916.1

Chemical Absolute Identifiers

CAS Number

1401-69-0

PubChem CID

5280440

Molecular Formula

C46H77NO17

Molecular Weight

916.1 g/mol

Exact Mass

915.51915

InChIKey

WBPYTXDJUQJLPQ-VMXQISHHSA-N

IUPAC Name

2-[(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde

SMILES String

CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC

Physical Properties

Melting Point

128–132 °C

Water Solubility

5 mol/L

pKa

7.73

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Tylosin (CAS 1401-69-0) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C46H77NO17 and molecular weight 916. 10 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Protein deacetylase HDAC6 (Homo sapiens) — 2 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Protein deacetylase HDAC6

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Tylosin

Names & Synonyms

Tylosin ATylosineTilosinaTylocineTylan
Show all synonyms
TylosinumFradizineVubityl 200BiloVetTylosin BaseTartrate, TylosinTylan 50Hydrochloride, TylosinTylan 200Tylosin Tartrate (Salt)Tylovet 200 mg/mL InjectionTylan 200 Injection, Tylan 50 InjectionTylosin-d3 (100 Mug/mL in Methanol)Tylosine [INN-French]Tylosinum [INN-Latin]
External Identifiers
EC NUMBER: 215-754-8DSSTOX SUBSTANCE ID: DTXSID3043996CHEMBL ID: CHEMBL42743CHEBI ID: CHEBI:17658UNII: YEF4JXN031DRUGBANK ID: DB11475KEGG ID: C01457KEGG ID: D02490METABOLOMICS WORKBENCH ID: 21277NCI THESAURUS CODE: C84234RXCUI: 995505WIKIDATA ID: Q411462
Experimental Spectrum References
13C NMR Spectra
Literature & Patent References
DOI 10.1021/acsmedchemlett.4c00458Design, Synthesis, and Activity Evaluation of C-23-Modified 5-<i>O</i>-Mycaminosyltylonolide Derivatives.PMID 39691534Design, Synthesis, and Activity Evaluation of C-23-Modified 5-<i>O</i>-Mycaminosyltylonolide Derivatives.DOI 10.1016/j.ejmech.2022.114495Design, synthesis and activity against drug-resistant bacteria evaluation of C-20, C-23 modified 5-O-mycaminosyltylonolide derivatives.PMID 35675753Design, synthesis and activity against drug-resistant bacteria evaluation of C-20, C-23 modified 5-O-mycaminosyltylonolide derivatives.DOI 10.6019/CHEMBL4808148HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activatorsDOI 10.21203/rs.3.rs-23951/v1Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collectionDOI 10.6019/CHEMBL4495564Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screenDOI 10.6019/CHEMBL4495565Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

TildipirosinCAS 328898-40-4
ErythromycinCAS 114-07-8
Erythromycin, cyclic 11,12-carbonateCAS 55224-05-0
9-Deoxo-9a-aza-9a-homoerythromycin ACAS 76801-85-9
RoxithromycinCAS 80214-83-1

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 328898-40-4TildipirosinCAS 100-88-9CyclamateCAS 1000787-75-6TegobuvirCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylateCAS 1018142-22-76-cyclopropyl-1-(2,2-difluoroethyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acidCAS 1018144-00-72-(3-Cyclopropyl-6-isopropyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acid

RFQ questions for CAS 1401-69-0

What are the key identifiers for Tylosin (CAS 1401-69-0)?

Tylosin is identified by CAS 1401-69-0, with molecular formula C46H77NO17, molecular weight 916.1, InChIKey WBPYTXDJUQJLPQ-VMXQISHHSA-N.

Does CAS 1401-69-0 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Protein deacetylase HDAC6. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 1401-69-0?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Tylosin?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 1401-69-0 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.